Enjoying this bite?
Sign in (free) to track this channel, unlock new bites the moment they drop, and search every summary we've ever made.
Source: YouTube. Summary is AI-generated from the video's captions and may contain errors. It does not represent the views of TubeBite, the creator, or YouTube. Watch the original before relying on anything important.
SUMMARY
Parkev Tatevosian, CFA, analyzes C3.ai's recent restructuring, significant revenue volatility, and the return of former CEO Thomas Siebel. The discussion covers financial performance, valuation metrics, and a revised investment outlook for the stock.
MAIN POINTS
- C3.ai announces a 35% workforce reduction to cut costs following inconsistent revenue growth.
- Revenue collapses below $250 million after CEO Thomas Siebel resigns due to health issues, but he later announces his return.
- Operating profit margin worsens to negative 195%, and returns on invested capital decline to -60%.
- Share price drops from $14 to below $8 before partially recovering to around $10, with revised cash flow projections remaining negative until 2029.
- C3.ai's beta of 2.07 indicates high volatility, and the discounted cash flow valuation suggests the stock is overvalued at current prices.
- The recommendation is downgraded to hold, with a suggested entry price below $7 and the update dated August 14th, 2026.
DETAILED ANALYSIS
C3.ai is undergoing a significant restructuring, reducing its workforce by 35% from 1,075 to 700 employees in an effort to control costs amid ongoing challenges in generating consistent revenue growth. The company's revenue trajectory has been notably volatile, with growth from $160 million in 2020 to approximately $350 million in trailing twelve-month revenue, followed by a sharp decline to below $250 million. This downturn coincided with the resignation of CEO Thomas Siebel due to health concerns, highlighting his critical role in the sales process.
Siebel's return to the company is seen as a potential catalyst for improved sales performance, given his historical impact on closing deals.
Financially, C3.ai's operating profit margin has remained negative throughout its recent history, plunging to -195% in the latest period. Returns on invested capital, which showed some improvement in 2021, have since deteriorated to -60%. The stock's forward price-to-sales ratio of 5.955 is near its historical lows, reflecting market skepticism.
Share price performance in 2026 has been turbulent, starting at $14, dropping below $8, and recovering to about $10. Revised cash flow projections indicate continued negative free cash flow through fiscal years 2026 to 2028, with a potential turnaround not expected until 2029.
C3.ai's stock exhibits high volatility, with a beta of 2.07, meaning its price movements are more than twice as volatile as the S&P 500. Based on discounted cash flow analysis, the estimated fair value of the stock is $6.57, compared to a current market price of $9.93, suggesting a 34% downside risk over the next 12 to 18 months. The recommendation is to hold rather than buy at current levels, with a more attractive entry point identified at $7 or below.
This updated outlook was formalized on August 14th, 2026.
LINKS
- YouTube channel membership for exclusive perks and early access.
- The Motley Fool special offer for stock recommendations.
- Parkev Tatevosian's book on a six-step investing framework.
- Fiscal.ai investment research platform with a viewer discount.
- Webull investing platform sign-up with bonus shares.
- Substack newsletter subscription for monthly updates.